The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Modeling the ACMG/AMP variant classification guidelines as a Bayesian classification framework
Open accessAbstract
Purpose We evaluated the American College of Medical Genetics and Genomics/Association for Molecular Pathology (ACMG/AMP) variant pathogenicity guidelines for internal consistency and compatibility with Bayesian statistical reasoning.Methods The ACMG/AMP criteria were translated into a naive Bayesian classifier, assuming four levels of evidence and exponentially scaled odds of pathogenicity. We tested this framework with a range of prior probabilities and odds of pathogenicity.Results We modeled the ACMG/AMP guidelines using biologically plausible assumptions. Most ACMG/AMP combining criteria were compatible. One ACMG/AMP likely pathogenic combination was mathematically equivalent to pathogenic and one ACMG/AMP pathogenic combination was actually likely pathogenic. We modeled combinations that include evidence for and against pathogenicity, showing that our approach scored some combinations as pathogenic or likely pathogenic that ACMG/AMP would designate as variant of uncertain significance (VUS).Conclusion By transforming the ACMG/AMP guidelines into a Bayesian framework, we provide a mathematical foundation for what was a qualitative heuristic. Only 2 of the 18 existing ACMG/AMP evidence combinations were mathematically inconsistent with the overall framework. Mixed combinations of pathogenic and benign evidence could yield a likely pathogenic, likely benign, or VUS result. This quantitative framework validates the approach adopted by the ACMG/AMP, provides opportunities to further refine evidence categories and combining rules, and supports efforts to automate components of variant pathogenicity assessments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“This procedure yielded a prior probability of pathogenicity (prevalence in the data set) of 4.41%, higher than that estimated previously for an exome of a healthy individual19 using a similar procedure but lower than the prevalence of 10% assumed by Tavtigian et al.9 for clinical sequencing data.”
From Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3/BP4 criteria (2022) · cites this paper as [9]
The cited source says what the claim attributes to it.
In the citing paper
“Under reasonable assumptions, we used a positive likelihood ratio of pathogenicity to quantify the strength of evidence that corresponds to a supporting level of evidence and established that, within this framework, the strength of evidence required for moderate, strong, and very strong rose exponentially.9”
From Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3/BP4 criteria (2022) · cites this paper as [9]
The cited source says what the claim attributes to it.
In the citing paper
“We have previously modeled the ACMG/AMP rules for combining evidence and showed how they fit a probabilistic framework.9”
From Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3/BP4 criteria (2022) · cites this paper as [9]
The cited source says what the claim attributes to it.
In the citing paper
“These fractions were smaller than the experience-based prior probability assumed by Tavtigian et al.9 (10%) and the prior probability that was estimated in this study using the gnomAD set (4.41%).”
From Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3/BP4 criteria (2022) · cites this paper as Tavtigian et al.9
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
Plon, S. E., Eccles, D. M., Easton, D., Foulkes, W. D., Genuardi, M., Greenblatt, M. S., Hogervorst, F. B. L., Hoogerbrugge, N., Spurdle, A. B., Tavtigian, S. V., et al. (2008) · Human Mutation · doi:10.1002/humu.20880 · Cited by 912
Self-citationInSiGHT, O. B. O., Thompson, B. A., Spurdle, A. B., Plazzer, J., Greenblatt, M. S., Akagi, K., Al‐Mulla, F., Bapat, B. V., Bernstein, I., Capellá, G., et al. (2013) · Nature Genetics · doi:10.1038/ng.2854 · Cited by 468
Self-citationEaston, D. F., Deffenbaugh, A. M., Pruss, D., Frye, C., Wenstrup, R. J., Allen-Brady, K., Tavtigian, S. V., Monteiro, A. N. A., Iversen, E. S., Couch, F. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/521032 · Cited by 455
Self-citationGoldgar, D. E., Easton, D. F., Deffenbaugh, A. M., Monteiro, Á. N. A., Tavtigian, S. V., & Couch, F. J. (2004) · The American Journal of Human Genetics · doi:10.1086/424388 · Cited by 388
Self-citationTavtigian, S. V., Byrnes, G. B., Goldgar, D. E., & Thomas, A. (2008) · Human Mutation · doi:10.1002/humu.20896 · Cited by 233
Self-citationAnalysis of missense variation in human BRCA1 in the context of interspecific sequence variation
Abkevich, V., Zharkikh, A., Deffenbaugh, A. M., Frank, D., Chen, Y., Shattuck, D., Skolnick, M. H., Gutin, A., & Tavtigian, S. V. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.015867 · Cited by 157
Self-citationA Full-Likelihood Method for the Evaluation of Causality of Sequence Variants from Family Data
Thompson, D. J., Easton, D. F., & Goldgar, D. E. (2003) · The American Journal of Human Genetics · doi:10.1086/378100 · Cited by 141
Thompson, B. A., Goldgar, D. E., Paterson, C. A., Clendenning, M., Walters, R., Arnold, S., Parsons, M. T., Walsh, M. D., Gallinger, S., Haile, R. W., et al. (2012) · Human Mutation · doi:10.1002/humu.22213 · Cited by 95
Self-citationThompson, B. A., Greenblatt, M. S., Vallee, M. P., Herkert, J. C., Tessereau, C., Young, E. L., Adzhubey, I. A., Li, B., Bell, R., Feng, B., et al. (2013) · Human Mutation · doi:10.1002/humu.22214 · Cited by 95
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–595 of 595
Kim, H. H., Kim, D.-W., Woo, J., & Lee, K. (2024) · Figshare · doi:10.6084/m9.figshare.26696070
Rañola, J. M. O., Horton, C., Pesaran, T. F., Fayer, S., Starita, L. M., & Shirts, B. H. (2024) · Figshare · doi:10.6084/m9.figshare.26962405
Kim, H. H., Kim, D.-W., Woo, J., & Lee, K. (2024) · Figshare · doi:10.6084/m9.figshare.26696067
Liu, S., Zhong, M., Huang, Y., Zhang, Q., Chen, T., Xu, X., Peng, W., Wang, X., Feng, X., Kang, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.24864295
Scott, A. J., Hernandez, F., Chamberlin, A. C., Smith, C., Karam, R., & Kitzman, J. O. (2023) · Figshare · doi:10.6084/m9.figshare.22598648
Gunning, A. C., & Wright, C. F. (2024) · Figshare · doi:10.6084/m9.figshare.26652606
Cannon, S., Williams, M., Gunning, A. C., & Wright, C. F. (2023) · Figshare · doi:10.6084/m9.figshare.22616807
Gunning, A. C., & Wright, C. F. (2024) · Figshare · doi:10.6084/m9.figshare.26652603
Scott, A. J., Hernandez, F., Chamberlin, A. C., Smith, C., Karam, R., & Kitzman, J. O. (2023) · Figshare · doi:10.6084/m9.figshare.22598657
Kim, H. H., Kim, D.-W., Woo, J., & Lee, K. (2024) · Figshare · doi:10.6084/m9.figshare.26696073
Madero, L. F. L., Dioulo, J. A. M. B. A., Arano, C. Z. M., Ramírez, A. C. F., & Castañeda-de-la-Fuente, A. (2026) · Springer eBooks · doi:10.1007/978-981-95-4770-8_2
Case Report: Preventing X-linked retinoschisis transmission via MARSALA-based PGT-M
Li, J., Wen, X., Ou, Z., Fang, X., Du, J., Lin, X., Ke, W., Wu, J., & Liu, N. (2026) · Frontiers in Ophthalmology · doi:10.3389/fopht.2025.1734044
Adams, B., Lichten, L., Heyward, A., & Govil, N. (2026) · Journal of Community Genetics · doi:10.1007/s12687-025-00834-y
Xia, X., Zhao, G., Li, J., & Yuan, X. (2025) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm66473.2025.11356196
Farquhar, H. (2026) · Research Square · doi:10.21203/rs.3.rs-8735672/v1
Konovalov, F. A. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.09.704882
Fernández‐Hernández, L., Enríquez‐Flores, S., Hernández‐Martínez, N. L., Abreu-González, M., Lieberman-Hernández, E., Rodríguez-González, G., Ruvalcaba, S. R., & Reyna‐Fabián, M. E. (2026) · Genes · doi:10.3390/genes17020231
Refinement of the classification of DDX41 variants through analysis of aggregated clinical datasets
Tiong, I. S., Hunter, S., Kankanige, Y., Mehta, N. N., Chisholm, R. A., Wu, S., Li, J., Casan, J. M. L., Chan, K. L., Godley, L. A., et al. (2026) · Leukemia · doi:10.1038/s41375-026-02886-6
Scaling genomic reanalysis to unlock diagnoses and transform rare disease care
Rockowitz, S., Shao, W., French, C., Truong, T. K., Hagen, J., McGonigle, R., Geltzeiler, A., Sheidley, B. R., Smith, L. A., D’Gama, A. M., et al. (2026) · Human Genetics and Genomics Advances · doi:10.1016/j.xhgg.2026.100582
Chu, A. T. W., Chung, C. C. Y., Luk, H., Cheng, S. S. W., Hayeems, R. Z., Luca, S., & Chung, B. H. (2026) · Communications Medicine · doi:10.1038/s43856-026-01441-9
Artificial Intelligence in Human Genetics
Brandes, N. (2026) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-111124-032550
Language models reveal evidence gaps in variants of uncertain significancePreprint
Li, W., Bhat, V., Yu, T., Lebo, M. S., Žitnik, M., & Cassa, C. A. (2026) · medRxiv · doi:10.64898/2026.02.28.26347206
Drackley, A., Skol, A. D., Rand, C. M., Weese‐Mayer, D. E., & Yap, K. L. (2026) · Human Mutation · doi:10.1155/humu/8001520
Man, T., Sun, H., Hao, X., Liu, X., & He, Y. I. H. U. A. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1726544
Navitski, A., & Layman, L. C. (2025) · Seminars in Reproductive Medicine · doi:10.1055/a-2781-8392
Yamazawa, K., Ueki, A., Kuga, A., Hinoi, T., Niitsu, H., Minatogawa, M., Kawano, J., Minami, S., Okawa, M., Takei, J., et al. (2026) · Journal of Medical Genetics · doi:10.1136/jmg-2025-111305
Dubé, J. B., Kim, S., Lau, L. Y. S., Higginbotham, T., Marshall, C. R., & Jobling, R. (2026) · Genetics in Medicine Open · doi:10.1016/j.gimo.2026.104395
Dai, Z., Haque, B., Xi, S., & Costain, G. (2026) · Genome Medicine · doi:10.1186/s13073-026-01631-z
Moghadasi, S., Monajemi, R., Braspenning, M. E., Vreeswijk, M. P. G., & Rodríguez-Girondo, M. D. M. (2026) · Human Genetics · doi:10.1007/s00439-025-02816-z
Typische Elemente und Aussagen eines genetischen Befunds
Zenker, M. (2026) · Die Gastroenterologie · doi:10.1007/s11377-026-00975-7
Introduction to genetics of skeletal and mineral metabolic diseases
Newey, P. J., Lovegrove, C. E., Howles, S., Whyte, M. P., & Thakker, R. V. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-13683-2.00015-3
BRCA2 c.7847C>T (p.Ser2616Phe): A Pathogenic Variant Specific to the Japanese Population
Yamazawa, K. (2026) · Springer eBooks · doi:10.1007/978-981-95-6580-1_23
DNM1-related disorder is characterized by recurrent variants and phenotypic homogeneityPreprint
Harrison, A., Ganesan, S., Xie, H. M., Parthasarathy, S., McKee, J. L., Magielski, J. H., Thalwitzer, K. M., Lobo, R., Pendziwiat, M., van Baalen, A., et al. (2026) · medRxiv · doi:10.64898/2026.04.05.26350183
Measuring disease likelihood in genomic ascertainment
Sapp, J. C., Lewis, K. L., Modlin, E. W., Davidson, A., Early, C. L., Buchanan, A. H., Darling, A., Mahder, J., McCormick, C. Z., de Moya, A. J., et al. (2026) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2026.03.009
Self-citationFunctional assays for BRCA1 and BRCA2 variant analysis: new tools and their applications
Bose, M., Faseela, E. E., Rossing, M., & Sørensen, C. S. (2026) · npj Breast Cancer · doi:10.1038/s41523-026-00949-6
Park, K., & Cho, H.-E. (2026) · Diagnostics · doi:10.3390/diagnostics16081180
Matton, C., Velde, J. V. D., Bruyne, M. D., de Sompele, S. V., Hooghe, S., Syryn, H., Bauwens, M., D’haene, E., Dheedene, A., Cools, M., et al. (2026) · Human Mutation · doi:10.1155/humu/8478740
PEHLEVAN, Ö. S., Yaman, G. G., Gök, A., & ORGUN, L. T. (2026) · Journal of Paediatrics and Child Health · doi:10.1111/jpc.70401
Allen, S., Rowlands, C. F., Garrett, A., Couch, F. J., Richardson, M. E., Pesaran, T. F., Pethick, J., Lavelle, K., McRonald, F. E., Vernon, S., et al. (2026) · medRxiv · doi:10.64898/2026.05.13.26353095
Bawa, P., Rzasa, J., Kerkhof, J., Levy, M. A., Sadiković, B., Gupta, S., Sharma, R., Srivastava, P., Panigrahi, I., & Kaur, A. (2026) · Molecular Syndromology · doi:10.1159/000552586
Yang, J., He, T.-T., Gu, Y.-N., Xue, Y., Chen, Q., Yu, M., Qiao, S., & Shi, S.-J. (2026) · Asian Journal of Andrology · doi:10.4103/aja202611
Optimising POU3F4 variant interpretation through gene-specific evidence in X-linked hearing loss
Geng, J., Zhao, Y., Huang, Y., Xiong, W., Zhong, M., Wang, C., Wang, X., Zhang, Q., Tang, T., Chen, M., et al. (2026) · EBioMedicine · doi:10.1016/j.ebiom.2026.106318
Yan, D., Liu, X., Gu, C., Cai, Y., Fan, W., Zhang, C., Li, D., Shu, J., Wang, H., & Cai, C. (2026) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-026-04409-z
Liu, F.-L., Chen-Zhang, Y., Huang, J.-M., Jiang, Q., Liu, J., & Yang, J.-Y. (2026) · Functional & Integrative Genomics · doi:10.1007/s10142-026-01896-y
Wang, Z., Chen, X., Tang, L., Wu, X., Huang, A., & Zhang, H. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08368-8
Saturation Genome Editing reveals the functional impact of RAD51D and XRCC2 variantsPreprint
Casadei, S., Snyder, M. W., Woo, I. M. H., Smith, N. T., Best, S., Garge, R. K., Rodriguez-Salas, L., Wenman, C., Seid, O., Hosokai, A., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.12.731983 · Cited by 1
The Performance of In Silico Prediction Tools for Variant Curation in a Panel of Cancer Genes
Nelson, N. E., Niaz, A., Fairfax, K. A., Bryan, T. M., Lucas, S. E. M., & Dickinson, J. L. (2026) · Human Mutation · doi:10.1155/humu/8817550
Bindra, J., Maggacis, R., Hayes, L., Field, M., Vakulin, C., Ephraums, L. A., Sey, A. A., Tacon, L. J., Sousa, S. M. C. D., & Clifton-Bligh, R. J. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag239
Verlee, M., Hitzert, M. M., van Loon, R. L. E., Mosquera, L. M., Groote, K. D., Backer, J. F. A. D., Demulier, L., Meerschaut, I., Jongbloed, J. D. H., Vos, Y. J., et al. (2026) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.125.005385
Laganà, A., Iaquinta, G., Santopietro, M., Luzi, G., Ragazzo, M., Angeloni, S., Cerroni, C., Tamburini, A., Crescenzi, S. L., Tatarelli, C., et al. (2026) · Experimental Hematology · doi:10.1016/j.exphem.2026.105472
Hayeck, T. J., Sottolano, C. J., Blair, J. J., Xenakis, M. N., Spinner, N. B., & Gilbert, M. A. (2026) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2026.06.016
Kertai, M. D., Zhao, X., Bastarache, L. A., Roberts, D. A., Jewell, E. S., Bertucci, E. M., Zöllner, S., & Douville, N. J. (2026) · British Journal of Anaesthesia · doi:10.1016/j.bja.2026.04.079
Nguyen, H.-T., Vu, M.-D., Nguyen, D. D., Dinh, P.-N., Hoang, V.-Q., Bui, L.-T. N., Nguyen, D.-T., Do, P.-H., Tong, T.-O., Nguyen, V.-H., et al. (2026) · BMC Cancer · doi:10.1186/s12885-026-16085-0
Goel, H., Garg, G., Barakat, T. S., Barcia, G., Bourgois, A., Charles, P., Gerasimenko, A., Jouret, G., Guimier, A., Hammer, T. B., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-10148333/v1
Genotype-Informed Characterization of Mild Renal Hypouricemia
Carrera, N., Urisarri, A., Fortes-González, P., Sánchez-Cazorla, E., Piñeiro, Y. G., de la Iglesia, A. M. B., Amigo, J., Díaz, C. M., Pedrosa, P., García-Murias, M., et al. (2026) · Kidney International Reports · doi:10.1016/j.ekir.2026.106711
García, J. B., García, M., Olivera, L. E., Rivera-Pedroza, C. I., & Soler, V. D. N. (2026) · Archives of Medical Research · doi:10.1016/j.arcmed.2026.103492
Zhang, X., Liu, X., Zhou, W., & Liao, Y. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1879157
Hao, X., Ye, Y., Liu, M., Zhang, Z. J., Ning, H., Wang, X., Tao, F., Huang, X., Du, J., & Li, T. X. (2026) · Frontiers in Genetics · doi:10.3389/fgene.2026.1870344
Urrutia, M., Brunello, F., Minaberry, L., Sansó, G., Brito, L. C., Grinspon, R. P., Marti, M. A., & Rey, R. A. (2026) · Sexual Development · doi:10.1159/sxd/aerag002
Godfrey, M., Levy, M. A., Campbell, C., Demain, L. A. M., Jenkinson, S., Hilton, S., Almoguera, B., Balasubramanian, M., Bijlsma, E. K., Blanco‐Kelly, F., et al. (2026) · European Journal of Human Genetics · doi:10.1038/s41431-026-02209-4
Liu, F., Zhou, Q., Chenzhang, Y., Ju, X., He, B., Huang, R., Li, C., Luo, F., & Yang, J. (2026) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-026-03997-w
Heterozygous HMGB1 variants and neurodevelopmental disorder: phenotypic and allelic spectrumPreprint
Goel, H., Treat, K. M., Wilson, T. E., Peron, A., Morleo, M., Nigro, V., Platzer, K., Krakowsky, R., Lertwilaiwittaya, P., Keren, B., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-10485683/v1
González‐Bustos, P., del-Águila-García, M. M., Roa-Chamorro, R., Atienza, M. M., Jaén-Águila, F., Corral, G. Á., Vargas‐Hitos, J. A., Mata, P., & Mediavilla-García, J. D. (2026) · Research Square · doi:10.21203/rs.3.rs-9741525/v1
Hata, Y., Yamaguchi, Y., Hirono, K., Ichimata, S., & Nishida, N. (2026) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-026-04676-y
The Tyrolean Founder MLH1 Variant c.836T>G Causes Lynch Syndrome Due to a Leaky Splice Effect
Horpaopan, S., Schamschula, E., Fiegl, H., Dapoz, H., Lutz‐Nicoladoni, C., Schnaiter, S., Amberger, A., Strasser, U., Lunzer, R., der Heidt, A. V., et al. (2026) · Biomolecules · doi:10.3390/biom16081200
Leveraging paired germline and somatic analysis to improve the classification of DDX41 variants
Malik, M. M. U. D. (2026) · British Journal of Haematology · doi:10.1111/bjh.70789
Neupane, B., Sivasubbu, S., & Shrestha, T. R. (2026) · Research Square · doi:10.21203/rs.3.rs-10540225/v1
Linga, B. G., Ibrahim, F. E., & Al-Dewik, N. I. E. (2026) · Genes · doi:10.3390/genes17091057
Fontana, A., Mastroianno, S., Fusco, C., Morlino, S., Ritrovato, L., Sturdà, F., Perrino, D., Micale, L., Bevere, E. M. L., Pedio, E., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-10391931/v1
PAH Variants Pathogenicity Classification
Zastrow, D. B., Lichter‐Konecki, U., & Craigen, W. J. (2026) · Springer eBooks · doi:10.1007/978-3-032-26690-3_14
Exploring the genetic spectrum of parkinsonism in Brazil
Ferreira, M. G., Tesson, C., Courtin, T., de Macedo, G. L., Tenório, R. B., Raskin, S., Lesage, S., Brice, A., & Teive, H. A. G. (2026) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2026.108958
Horie, M., 大野, 聖., Seiko, O. H. N. O., & Ai, T. (n.d.) · Institutional Repositories DataBase (IRDB)
How To Interpret a Genetic Testing Report for Dilated Cardiomyopathy
Patel, K., Jiang, N., & Kransdorf, E. P. (2026) · Journal of Cardiac Failure - Intersections · doi:10.1016/j.yjcafi.2026.08.006
Vasconcelos, A. P., Rocha, L., Fernandes, S., & Oliveira, J. P. (2026) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.70298
Amzaleg, Y., McDonnell, K. J., Idos, G., Mathai, C., Gray, S. W., Hampel, H., & Craig, D. W. (2026) · Human Mutation · doi:10.1155/humu/7456837
Empirically calibrated allele frequency thresholds for ACMG BA1, BS1 and PM2 evidence criteriaPreprint
Dubey, V. K., & Eisenhart, C. E. (2026) · medRxiv · doi:10.64898/2026.09.07.26362456
SCN4A Channelopathies: From Disease Mechanisms to Variant Interpretation
D′Ambrosio, P., Cipriano, L., Pugliese, A., Petillo, R., Ricciardi, D., Habetswallner, F., Rodolico, C., & Priolo, M. (2026) · Genes · doi:10.3390/genes17091116
Pathogenicity assessment of genetic variants in reproductive disorders
Silajiding, Z., Shen, L., Wang, M., Long, L., & Lu, Y. (2026) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-026-04032-8
Zhang, N. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.14.751496
The 10-Year Evolution of Sherloc, a Points-Based Framework for Genetic Variant Classification
Kobayashi, Y., Westbrook, M. J., Tan, C. A., Márquez‐Luna, C., Wahl, A., Swartzlander, D. B., Ouyang, K., & Daber, R. D. (2026) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2026.08.005
The Australian PreGen Study: Results From Prospective Prenatal Exome Sequencing in 275 Pregnancies
Rowntree, C., Fernihough, G., Long, S. S., Al-Shinnag, M., Wilson, A. M., Parmar, J., Hart, N., MacShane, M., Ross, K., Milnes, D., et al. (2026) · Prenatal Diagnosis · doi:10.1002/pd.70256
Shen, Q., Ma, J. G., Kroncke, B. M., Vandenberg, J. I., & Ng, C. (2026) · Heart Rhythm · doi:10.1016/j.hrthm.2026.09.044
Mechanism-selective deep mutational scanning distinguishes ERCC2 disease phenotypesPreprint
Çubuk, H., Aslanzadeh, V., Shang, Y., Plech, M., Pathak, A., Kudla, G., & Marsh, J. A. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.24.754105
Wang, F., Zhang, J., Lu, C., Wang, X., Gao, H., Fu, X., Liu, Y., Zhang, M., Chen, Y., Li, L., et al. (2026) · Diagnostics · doi:10.3390/diagnostics16193150
The prevalence of protein misfolding as a mechanism for hereditary deafness
Gogal, R. A., Cox, G. M., Kolbe, D. L., Odell, A. D., Ovel, C., McCormick, K., Hong, B., Azaiez, H., Casavant, T. L., Smith, R. J., et al. (2026) · PLoS Genetics · doi:10.1371/journal.pgen.1012085
Savy, S., Carro, G. H., Martín, M., Montes, F. A., Muñoz, N. S., Geysels, R. C., Peyret, V., Masini-Repiso, A. M., & Nicola, J. P. (2026) · Human Molecular Genetics · doi:10.1093/hmg/ddag105
Lyra, P. C. M., Brito, S., Parsons, M. J., Hu, C., Nepomuceno, T. C., Nguyen, N. P., Dalcolmo, L., Richardson, M. E., de Oliveira, G., da Silva, J., et al. (2026) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2026.09.013
Mullally, I., Smith, J. E., Bedöcs, P., McLean, T. W., Biesecker, L. G., Cook, G. A., Vietor, R., & Bera, A. (2026) · Genes · doi:10.3390/genes17101290
Self-citationCancer risks associated with BRCA1 and BRCA2 : Overview and management
Breen, K. E., Vashisth, S., & Liu, Y. L. (2026) · Cancer · doi:10.1002/cncr.70635
Ku, W.-J., Wei, T.-Y., Zhang, J., Kang, M.-X., Yu, G., Liu, J., Zhang, J., Hu, H.-Y., & Zhang, F. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1978944
Lens dislocation, OCTA, and archived FBN1 reports: An exploratory study
Çevik, M. Ö., Şimşek, M., Çevik, S. G., & Perente, İ. (2026) · PLoS ONE · doi:10.1371/journal.pone.0361193
Babazade, A., Dolaş, Y., Duzenli, T., Vural, O., Furtana, C., & Ergun, M. A. (2026) · doi:10.64898/2026.10.21.760715
Su, T.-Q., Zhao, Y., Liu, Q., Zhao, W.-G., Zhang, W.-M., Liu, T.-T., Gu, H., Du, J., Piao, C., & Wang, Y. (2026) · Gene · doi:10.1016/j.gene.2026.150453
Lores, J., Botia-Arciniegas, V., Ramírez‐Montaño, D., Pachajoa, H., Trujillo, D. A. V., & Prada‐Casilimas, M. (2026) · Clinical Genetics · doi:10.1111/cge.70263
The ENIGMA Likelihood Ratio Calculator
Goldgar, D. E., Michailidou, K., James, P., & Spurdle, A. B. (2024) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.13324449
Metadata
- Authors
- Tavtigian, S. V., Greenblatt, M. S., Harrison, S. M., Nussbaum, R. L., Prabhu, S. A., Boucher, K. M., & Biesecker, L. G.
- Affiliations
- University of Utah (US)
- University of Vermont (US)
- Harvard University (US)
- Invitae (United States) (US)
- Stanford University (US)
- National Institutes of Health (US)
- Corresponding author
- Tavtigian, Sean V.
- ORCID
- Venue
- Genetics in Medicine
- Publisher
- Elsevier BV
- Published
- 2018-09
- Volume
- 20
- Issue
- 9
- Pages
- 1054-1060
- ISSN
- 1098-3600 (ISSN-L)
- PMC
- PMC6336098
- OpenAlex
- W2781534540
- Cited by
- 590
- References
- 10
- Citations by year
- 2026: 113 · 2025: 81 · 2024: 77 · 2023: 72 · 2022: 84 · 2021: 57 · 2020: 48 · 2019: 37 · 2018: 18
- FWCI
- 24.53
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Genetics in Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- University of Connecticut
- Johns Hopkins University
- Wellcome Trust
- Huntsman Cancer Institute (P30CA042014)
- Invitae
- University of Cambridge
- National Institutes of Health
- University of North Carolina at Chapel Hill
- School of Medicine
- National Human Genome Research Institute (HG200388 03, U41HG009650, U41HG006834, U01HG007436, HG200387, HG200388, U01HG007437, U41HG009649, ZIAHG200388, U24HG009650, ZIAHG200387)
- National Cancer Institute (R01CA164944, R01CA121245, P30CA042014)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- variant pathogenicity assessment, Bayesian classification, naive Bayesian classifier, variants of uncertain significance, combining rules, prior probability
- MeSH terms
- Bayes Theorem, Genetic Testing, Humans, Software, Genetic Variation, Genome, Human, Sequence Analysis, DNA, Computational Biology, Genomics, High-Throughput Nucleotide Sequencing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review